A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Trametinib
The metabolism of Voxilaprevir can be decreased when combined with Trametinib.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Pazufloxacin
The metabolism of Voxilaprevir can be decreased when combined with Pazufloxacin.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Dosulepin
The metabolism of Voxilaprevir can be decreased when combined with Dosulepin.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Cyproterone acetate
The metabolism of Voxilaprevir can be increased when combined with Cyproterone acetate.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Deferasirox
The serum concentration of Voxilaprevir can be increased when it is combined with Deferasirox.
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Voxilaprevir.
Dichloralphenazone
Berotralstat
The serum concentration of Alpelisib can be increased when it is combined with Berotralstat.
Dichloralphenazone
Satralizumab
The serum concentration of Alpelisib can be decreased when it is combined with Satralizumab.
Dichloralphenazone
Oliceridine
The serum concentration of Oliceridine can be decreased when it is combined with Alpelisib.
Dichloralphenazone
Abametapir
The serum concentration of Alpelisib can be increased when it is combined with Abametapir.
Dichloralphenazone
Selpercatinib
The serum concentration of Selpercatinib can be decreased when it is combined with Alpelisib.
Dichloralphenazone
Rimegepant
The metabolism of Rimegepant can be increased when combined with Alpelisib.
Dichloralphenazone
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Alpelisib.
Dichloralphenazone
Lumateperone
The serum concentration of Lumateperone can be decreased when it is combined with Alpelisib.
Dichloralphenazone
Darolutamide
The serum concentration of Alpelisib can be increased when it is combined with Darolutamide.
Dichloralphenazone
Cenobamate
The serum concentration of Alpelisib can be decreased when it is combined with Cenobamate.
Dichloralphenazone
Voxelotor
The serum concentration of Voxelotor can be increased when it is combined with Alpelisib.
Dichloralphenazone
Lefamulin
The serum concentration of Lefamulin can be increased when it is combined with Alpelisib.
Dichloralphenazone
Avapritinib
The serum concentration of Avapritinib can be decreased when it is combined with Alpelisib.
Dichloralphenazone
(S)-Warfarin
The serum concentration of (S)-Warfarin can be decreased when it is combined with Alpelisib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3